Elective hip replacement surgery has grow in popularity to where it has become has become one of the most common surgeries in the U.S. with hundreds of thousands of operations performed year. This is partially because younger patients are getting artificial hip implants and because of the massive marketing push by the medical device manufacturing firms. The problem occurs when companies rush dangerous defective artificial hips onto the market without taking the time to do proper and required safety testing.
According to a recent news article from MedGadget, a new sales index and forecasting system is evaluating the global hip replacement market and has estimated that sales are to reach $5 billion a year by 2021. These companies are making a lot of money and they are trying to show “healthy” growth from quarter to quarter. While this is done in the name of efficiency to make shareholders happy, it also leads to corners being cut at the expenses of patients who have no idea they are about to receive a defective hip implant that can cause tremendous pain and suffering, lost time at work during the surgery and recovery, and many other types of legal damages. Continue reading